BAX stock page - price, fundamentals, dividends - iOCharts

BAX

82.11
+1.34 (1.66%)
Baxter International Inc (NYSE, USD)
Healthcare >
Medical Instruments & Supplies
Market cap
41.29B
Ent value
49.08B
Price/Sales
3.54
Price/Book
4.86
Div yield
1.36%
Div growth
3.74%
Growth years
4
FCF payout
40.81%
Trailing P/E
37.50
Forward P/E
20.43
PEG
3.88
EPS growth
13.20%
1 year return
-8.04%
3 year return
2.38%
5 year return
12.24%
10 year return
9.25%
Last updated: 2021-07-28

STOCK INFORMATION

Stock chart
Loading...
Stock price data
All-time high94.14
1y analyst estimate94.00
Beta0.68
EPS (TTM)2.18
Dividend per share1.12
Ex-div date3 Jun 2021
Next earnings date29 Jul 2021
Downside potential
Loading...
Downside potential data
BAXS&P500
Current price drop from All-time high-12.78%-0.46%
Highest price drop-68.86%-56.47%
Date of highest drop1 Apr 20039 Mar 2009
Avg drop from high-16.07%-11.53%
Avg time to new high25 days13 days
Max time to new high1406 days1805 days

DIVIDENDS

Dividend yield - 5y
Loading...
Dividend yield data
Dividend per share1.12
Dividend yield1.36%
Payout frequencyQuarterly
Maximum yield1.40%
Average yield1.11%
Minimum yield0.89%
Discount to avg yield18.28%
Upside potential22.37%
Yield as % of max yield97.76%
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
Dividend yield1.36%
Current yield distribution2.78%
Yield at 100% (Min)0.89%
Yield at 90%1.00%
Yield at 80%1.02%
Yield at 50% (Median)1.11%
Yield at 20%1.19%
Yield at 10%1.24%
Yield at 0% (Max)1.40%
Dividend per share
Loading...
Dividend per share data
Years of growth4 years
CCC status-
Dividend per share1.12
Payout frequencyQuarterly
Ex-div date3 Jun 2021
EPS (TTM)2.18
EPS (1y forward)4.02
EPS growth (5y)13.20%
EPS growth (5y forward)9.67%
Dividend growth
Loading...

Please create a free account or log in to access this chart

Dividend growth data
BAXS&P500
DGR MR14.29%7.68%
DGR TTM12.15%-2.66%
DGR 3 years16.12%5.82%
DGR 5 years3.74%6.23%
DGR 10 years4.07%9.64%
DGR 15 years7.65%6.71%
Time since last change announced91 days
EPS growth (5y)13.20%
EPS growth (5y forward)9.67%
Payout ratio
Loading...

Please create a free account or log in to access this chart

Payout ratio data
EPS coverageFCF coverage
TTM42.96%40.81%
Average--
Forward27.86%-

FINANCIALS

Per share
Loading...
Per share data
Current share count502.85M
EPS (TTM)2.18
FCF per share (TTM)2.30
Income statement
Loading...
Income statement data
Revenue (TTM)11.67B
Gross profit (TTM)4.59B
Operating income (TTM)1.57B
Net income (TTM)1.10B
EPS (TTM)2.18
EPS (1y forward)4.02
Margins
Loading...
Margins data
Gross margin (TTM)39.30%
Operating margin (TTM)13.46%
Profit margin (TTM)9.43%
Balance Sheet
Loading...

Please create a free account or log in to access this chart

Balance Sheet data
Cash3.18B
Net receivables1.92B
Total current assets7.86B
Goodwill3.11B
Intangible assets1.96B
Property, plant and equipment5.18B
Total assets19.47B
Accounts payable1.02B
Short/Current long term debt6.09B
Total current liabilities3.19B
Total liabilities10.98B
Shareholder's equity8.49B
Net tangible assets3.38B
Cash flow
Loading...

Please create a free account or log in to access this chart

Cash flow data
Operating cash flow (TTM)1.87B
Capital expenditures (TTM)709.00M
Free cash flow (TTM)1.16B
Dividends paid (TTM)473.00M
Financial returns
Loading...

Please create a free account or log in to access this chart

Financial returns data
Return on Equity12.62%
Return on Assets5.50%
Return on Invested Capital7.38%
Cash Return on Invested Capital7.77%
COMPANY DETAILS
BAX (Baxter International Inc) company logo
Marketcap
41.29B
Marketcap category
Large-cap
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Employees
50000
Investor relations
SEC filings
CEO
Jose Almeida
Country
USA
City
Deerfield
Stock type
Common stock
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Loading...